ahlam1399
09-15-2016, 07:02 PM
BRIEF-BioMarin an**unces EMA validation for treatment of Batten Disease
* BioMarin an**unces EMA validation of Brineura(cerliponase alfa) marketing authorization application fortreatment of CLN2 disease, a form of batten diseasehttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=PSy2dTYuRiw:vxA0h7EKq54:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=PSy2dTYuRiw:vxA0h7EKq54:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=PSy2dTYuRiw:vxA0h7EKq54:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=PSy2dTYuRiw:vxA0h7EKq54:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=PSy2dTYuRiw:vxA0h7EKq54:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/PSy2dTYuRiw
* BioMarin an**unces EMA validation of Brineura(cerliponase alfa) marketing authorization application fortreatment of CLN2 disease, a form of batten diseasehttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=PSy2dTYuRiw:vxA0h7EKq54:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=PSy2dTYuRiw:vxA0h7EKq54:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=PSy2dTYuRiw:vxA0h7EKq54:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=PSy2dTYuRiw:vxA0h7EKq54:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=PSy2dTYuRiw:vxA0h7EKq54:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/PSy2dTYuRiw